Campbell v. BP Exploration & Production, Inc.

District Court, E.D. Louisiana·Decided November 28, 2022·No. 2:17-cv-03119·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA

SHARON ARLETA CAMPBELL CIVIL ACTION

VERSUS NO. 17-3119

B.P. EXPLORATION & SECTION “R” (2) PRODUCTION, INC., ET AL.

ORDER AND REASONS Before the Court is BP Exploration & Production, Inc., BP America Production Company, and BP p.l.c.’s (collectively the “BP parties”) motion to exclude the testimony of plaintiff’s general causation expert, Dr. Jerald Cook,1 and their motion for summary judgment.2 Plaintiff opposes both motions.3 Plaintiff also filed a motion seeking admission of Dr. Cook’s testimony as a sanction for BP’s failure to conduct biomonitoring and dermal monitoring,4 which Campbell alleges amounted to spoliation. Defendants oppose plaintiff’s spoliation motion.5

1 R. Doc. 49. The remaining defendants, Halliburton Energy Services, Inc., Transocean Deepwater, Inc., Transocean Holdings, LLC, and Transocean Offshore Deepwater Drilling, Inc. join the BP parties’ motion to exclude the testimony of Dr. Cook. Id. at 1 n.1. 2 R. Doc. 50. The remaining defendants also join the BP parties’ motion for summary judgment. Id. at 1 n.1. 3 R. Docs. 53 & 54. 4 R. Doc. 58. 5 R. Doc. 66. For the following reasons, the Court grants defendants’ motion to exclude the testimony of Dr. Cook and denies plaintiff’s spoliation motion. Without Dr.

Cook’s expert report, plaintiff cannot establish the general causation element of her claims at trial. Accordingly, the Court also grants defendants’ motion for summary judgment.

I. BACKGROUND

This case arises from plaintiff’s alleged exposure to toxic chemicals following the Deepwater Horizon oil spill in the Gulf of Mexico. Plaintiff alleges that she performed cleanup work after the Deepwater Horizon oil spill beginning in June of 2010 until late-July of 2010 as well as August of 2012 until mid-2013.6 Plaintiff asserts that she experienced “continuous, personal, direct exposure [to crude oil and dispersants] . . . while working the cleanup operation . . . [at] Gulfport, Long

Beach and Biloxi, MS” during the relevant period.7 Plaintiff also represents that this exposure has resulted in the following conditions: hypertension, asthma, chest pain, shortness of breath, wheezing, acne, rash, skin itching, dermatitis, eczema, blistering, crusting, dryness/flaking, inflammation, redness, swelling, peeling,

6 R. Doc. 50-2 at 5. 7 Id. scaling, welts, insomnia, depression, headaches, dizziness, itching eyes, blurred vision, eye irritation, nausea, diarrhea, vomiting, joint pain, and “weakness.”8

Plaintiff’s case was originally part of the multidistrict litigation (“MDL”) pending before Judge Carl J. Barbier. Her case was severed from the MDL as one of the “B3” cases for plaintiffs who either opted out of, or were excluded from, the Deepwater Horizon Medical Benefits Class Action Settlement Agreement.9

Campbell is a plaintiff who opted out of the settlement.10 After plaintiff’s case was severed, it was reallocated to this Court. Plaintiff asserts claims for general maritime negligence, negligence per se, and gross negligence against the

defendants as a result of the oil spill and its cleanup.11 To demonstrate that exposure to crude oil, weathered oil, and dispersants can cause the symptoms plaintiff alleges in her complaint, she offers the testimony of Dr. Jerald Cook, an occupational and environmental physician.12 Dr. Cook is

plaintiff’s sole expert offering an opinion on general causation.13 In his June 21,

8 R. Doc. 50-3 at 1-2. 9 In re Oil Spill by Oil Rig “Deepwater Horizon” in the Gulf of Mex., on Apr. 20, 2010, No. MDL 2179, 2021 WL 6053613, at *2, 12 & n.12 (E.D. La. Apr. 1, 2021). 10 R. Doc. 1-1 at 2. 11 R. Doc. 29 ¶¶ 19-49.

12 R. Doc. 49-4 (Cook Report). 13 Plaintiff has also retained Dr. Rachel Jones, a certified industrial hygienist, to provide a report describing “the common, or shared, occupational exposures among worker[s]” who participated in the Deepwater Horizon response and cleanup. R. Doc. 50-5 at 4 (Jones Report). 2022 report, Dr. Cook utilizes a “general causation approach to determine if some of the frequently reported health complaints are indeed from the result of

exposures sustained in performing [oil spill] cleanup work.”14 Dr. Cook concludes that “[g]eneral causation analysis indicates” that the following conditions, among others, “can occur in individuals exposed to crude oil, including weathered crude oil”: rhinosinusitis, chronic obstructive pulmonary disease (“COPD”), bronchitis,

asthma, dermatitis, conjunctivitis, and dry eye disease.15 The BP parties contend that Dr. Cook’s expert report should be excluded on the grounds that that it is unreliable and unhelpful.16 Defendants also move for

summary judgment, asserting that if Dr. Cook’s general causation opinion is excluded, plaintiff is unable to carry her burden on causation.17 Plaintiff opposes both motions,18 and filed a motion seeking admission of Dr. Cook’s opinion as a sanction for BP’s alleged spoliation of evidence.19 The Court considers the parties’

motions below.

14 R. Doc. 49-4 at 16 (Cook Report). 15 Id. at 103-133. 16 R. Doc. 49. 17 R. Doc. 50-1 at 1-2. 18 R. Docs. 53 & 54. 19 R. Doc. 58. II. MOTION TO EXCLUDE DR. COOK’S TESTIMONY

A. Legal Standard

The district court has considerable discretion to admit or exclude expert testimony under Federal Rule of Evidence 702. See Gen. Elec. Co. v. Joiner, 522 U.S. 136, 138-39 (1997); Seatrax, Inc. v. Sonbeck Int’l, Inc., 200 F.3d 358, 371 (5th Cir. 2000). Rule 702 provides that an expert witness “qualified . . . by knowledge, skill, experience, training, or education may testify” if: (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case. Fed. R. Evid. 702. In Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Supreme Court held that Rule 702 “requires the district court to act as a gatekeeper to ensure that ‘any and all scientific testimony or evidence admitted is not only relevant, but reliable.’” Metrejean v. REC Marine Logistics, LLC, No. 08-5049, 2009 WL 3062622, at *1 (E.D. La. Sept. 21, 2009) (quoting Daubert, 509 U.S. at 589). This gatekeeping function applies to all forms of expert testimony. See Kumho Tire Co. v. Carmichael, 526 U.S. 137, 147 (1999). The Court’s gatekeeping function consists of a two-part inquiry into reliability and relevance. First, the Court must determine whether the proffered

expert testimony is reliable. The party offering the testimony bears the burden of establishing its reliability by a preponderance of the evidence. See Moore v. Ashland Chem. Inc., 151 F.3d 269, 276 (5th Cir. 1998). The reliability inquiry requires the Court to assess whether the expert’s reasoning and methodology

underlying the testimony are valid. See Daubert, 509 U.S. at 593.

Free access — add to your briefcase to read the full text and ask questions with AI

Campbell v. BP Exploration & Production, Inc., (E.D. La. 2022).

Campbell v. BP Exploration & Production, Inc. (Campbell v. BP Exploration & Production, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Little v. Liquid Air Corp.
37 F.3d 1069 (Fifth Circuit, 1994)
Moore v. Ashland Chemical Inc.
151 F.3d 269 (Fifth Circuit, 1998)
Seatrax, Inc. v. Sonbeck International, Inc.
200 F.3d 358 (Fifth Circuit, 2000)
Burleson v. Texas Department of Criminal Justice
393 F.3d 577 (Fifth Circuit, 2004)
Knight v. Kirby Inland Marine Inc.
482 F.3d 347 (Fifth Circuit, 2007)
Paz v. Brush Engineered Materials, Inc.
555 F.3d 383 (Fifth Circuit, 2009)
Seaman v. Seacor Marine L.L.C.
326 F. App'x 721 (Fifth Circuit, 2009)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
General Electric Co. v. Joiner
522 U.S. 136 (Supreme Court, 1997)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Miller v. Pfizer, Inc.
356 F.3d 1326 (Tenth Circuit, 2004)